Skip to main content
. 2020 Feb 4;14:497–508. doi: 10.2147/DDDT.S237957

Table 1.

HDAC1 and HDAC2 Inhibitory Activities of the Newly Synthesized Ligustrazine-Based Derivatives 7a-7c and 8a, b

Compound IC50 (nM)
HDAC1 HDAC2
7a 114.3 ± 0.44 53.7 ± 0.05
7b 2434.7 ±1.25 132.3 ± 0.12
7c 263.5 ± 1.27 205.4 ± 0.43
8a 468.1 ± 0.08 168.8 ± 0.13
8b 1800.1 ± 0.45 112.9 ± 0.09
Dacinostat 129.4 ± 0.07 136.3 ± 0.11

Note: Data were expressed as mean ± standard error (S.E.) of three independent experiments.